H. Lundbeck

Pharmaceutical research, development and manufacturing focused on treatments for brain diseases and mental health conditions

Turku, FinlandFounded 1928lundbeck.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-29

Recent signals

What changed at H. Lundbeck in the last 6 months, newest first. Each line links to its public source.

  • 10 Nov 2026 In the news · Lundbeck raises its full-year guidance prnewswire.com

Get signals like these for the companies you sell to →

About H. Lundbeck

Lundbeck is a pharmaceutical company focused on brain diseases. Its work spans research, development, manufacturing and commercialization of pharmaceutical products.

Its products treat neurological and psychiatric disorders, including depression, anxiety, psychosis, Parkinson’s disease and Alzheimer’s disease. The company serves people living with these conditions through pharmaceutical therapies.

The Finnish legal entity is Oy H. Lundbeck Ab, based in Turku, and was founded in 1928. Lundbeck describes itself as a global company with offices worldwide.

Product: Researches, develops, manufactures and commercializes pharmaceutical treatments for brain diseases and mental health conditions.

Public tenders won

3 tenders won since 1 Jan 2024 from 3 public buyers in Finland, worth €136.0M as awarded. From EU award notices (TED) that name H. Lundbeck by its registry number.

  • 8 Sep 2026 Pohjois-Pohjanmaan hyvinvointialue · Lääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027 · €142 notice
  • 10 Mar 2025 Vankiterveydenhuollon yksikkö · Jälki-ilmoitus. Lääkevalmisteiden ja niihin rinnastettavien tuotteiden hankintaa koskeva tarjouspyyntö hankintakaudelle 2025-2026 · €6.0M notice
  • 12 Apr 2024 Sansia Oy · Lääkevalmisteet sekä niihin rinnastettavat valmisteet Itä-Suomen yhteistyöalueelle · €130.0M notice

Open tenders like these →

Jobs at H. Lundbeck

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Herantis Pharma

    Develops experimental therapies for people with Parkinson’s disease
    Espoo, FinlandBiotech & pharmaFounded 2008
    New on Evolc
  • HumGel

    Human tumor-derived cell matrix (MyoGel) for cancer research labs running invasion and drug-testing assays
    Oulu, FinlandBiotech & pharmaFounded 2026
    Young companyNew on Evolc
  • Hytest

    Immunological reagents, antibodies and antigens for IVD manufacturers and research labs
    Turku, FinlandBiotech & pharmaFounded 1994
    New on Evolc
  • Jilab

    Contract pathology and digital imaging services for pharmaceutical drug trials
    Tampere, FinlandBiotech & pharmaFounded 2003
    New on Evolc
  • KÄÄPÄ BioTech

    Standardised functional mushroom extracts for pharmaceutical, nutraceutical and wellness product developers
    Karjalohja, FinlandBiotech & pharmaFounded 2018
    New on Evolc
  • Karo Healthcare

    Consumer healthcare company marketing everyday health products in over 90 markets, mainly Europe and the Nordic countries
    Turku, FinlandBiotech & pharmaFounded 2018
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • AWS
  • Apache